Article Information
History
- March 13, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Mar Pujades-Rodriguez, PhD1,*,†,
- Ann W Morgan, PhD2,3,
- Richard M Cubbon, PhD2 and
- Jianhua Wu, PhD4,*
- 1Leeds Institute of Health Sciences, School of Medicine, University of Leeds, Leeds United Kingdom
- 2Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds United Kingdom
- 3NIHR Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Chapel Allerton Hospital, Leeds, Leeds United Kingdom
- 4School of Dentistry, University of Leeds, Leeds United Kingdom
- ↵†Corresponding author:
Mar Pujades-Rodriguez, Leeds Institute of Health Sciences, University of Leeds, Clarendon Way, Leeds, LS2 9NL, United Kingdom. Tel. +44 (0)11 3206 9253; Fax. +44 (0)113 3438702. Email: M.D.M.PujadesRodriguez{at}leeds.ac.uk
↵* These authors equally contributed to this work.
Posted March 13, 2020.
Dose-dependent oral glucocorticoid cardiovascular risk in people with immune-mediated inflammatory diseases
